Immune thrombocytopenia (ITP) in a pediatric patient positive for SARS-CoV-2

Hoi See Tsao, Hannah M. Chason, Deirdre M. Fearon

Research output: Contribution to journalArticlepeer-review

44 Scopus citations


Immune thrombocytopenia (ITP) is a potential presentation of COVID-19. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral testing should be considered in these patients to allow for appropriate hospital triaging and isolation to limit community spread and health care worker infection during epidemics or pandemics. ITP is characterized by isolated thrombocytopenia. Approximately two-thirds of children with primary ITP have a history of a viral infection during the previous month.1, 2Viruses commonly identified as triggers include cytomegalovirus, hepatitis C, herpes, varicella zoster, Epstein-Barr, influenza, and HIV.3-7In this case report, we describe the first documented case of a pediatric patient with ITP who tested positive for SARS-CoV-2. This case raises awareness of ITP as a possible pediatric presentation of coronavirus disease.

Original languageEnglish (US)
Article numbere20201419
Issue number2
StatePublished - Aug 1 2020
Externally publishedYes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Immune thrombocytopenia (ITP) in a pediatric patient positive for SARS-CoV-2'. Together they form a unique fingerprint.

Cite this